| Yetunde A Olaniyi, RPH | |
|
10500 Campus Way S, Upper Marlboro, MD 20774-1309 | |
| (301) 324-7098 | |
| Not Available |
| Full Name | Yetunde A Olaniyi |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 10500 Campus Way S, Upper Marlboro, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093413460 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 29049 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Yetunde A Olaniyi, RPH 10500 Campus Way S, Upper Marlboro, MD 20774-1309 Ph: () - | Yetunde A Olaniyi, RPH 10500 Campus Way S, Upper Marlboro, MD 20774-1309 Ph: (301) 324-7098 |
News Archive
In a study that has implications for humans with inflammatory diseases, researchers from Case Western Reserve University School of Medicine and colleagues have found that, given over a six-week period, the artificial sweetener sucralose, known by the brand name Splenda, worsens gut inflammation in mice with Crohn's-like disease, but had no substantive effect on those without the condition.
Hospital industry groups responded Tuesday to the warning issued by Health and Human Services Secretary Kathleen Sebelius and Attorney General Eric Holder, saying that the federal government shares part of the blame, because it hasn't provided hospitals adequate guidance on billing for common services.
A new research from the University of Helsinki showed for the first time how the pre-immunization acquired through common childhood vaccines can be used to enhance therapeutic cancer treatment.
Researchers and clinicians from across the UK have been part of a pan-European team that has developed the first Europe wide strategy for the prevention of type 2 diabetes. The project received substantial funding of -1.2 million from the European Union.
Cumberland Pharmaceuticals Inc. today announced the publication of a patient preference study evaluating Kristalose (lactulose) for Oral Solution, a prescription laxative packaged as a crystalline powder, compared to liquid lactulose products.
› Verified 4 days ago
Dr. Michael D Olaiya, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10908 Mount Lubentia Way, Upper Marlboro, MD 20774 Phone: 240-461-9554 | |
Sandy Apugo, DR. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10203 Brightfield Ln, Upper Marlboro, MD 20772 Phone: 240-476-8468 | |
Michelle D Harvey, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1221 Mercantile Ln, Upper Marlboro, MD 20774 Phone: 301-618-5500 | |
Richmond Muraguri, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9530 Crain Hwy, Upper Marlboro, MD 20772 Phone: 301-868-0303 Fax: 301-868-1812 | |
Dr. Bonnie Li-macdonald, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1221 Mercantile Ln, Upper Marlboro, MD 20774 Phone: 301-618-5500 | |
Simon Onukaogu, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5100 Brown Station Rd, Upper Marlboro, MD 20772 Phone: 301-627-1500 |